# Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

> **NCT00666016** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 22 (actual)

## Conditions studied

- Non-Alcoholic Steatohepatitis (NASH)

## Interventions

- **DRUG:** TRO19622
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00666016
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-15
- **Primary completion:** 2009-02-05
- **Final completion:** 2009-02-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666016, "Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00666016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*